Home
>
National Drug Code (NDC)
>
Epoprostenol Sodium
Epoprostenol Sodium - 0703-1985-01 - (Epoprostenol Sodium)
Drug Information of Epoprostenol Sodium
| Product NDC: | 0703-1985 |
| Proprietary Name: | Epoprostenol Sodium |
| Non Proprietary Name: | Epoprostenol Sodium |
| Active Ingredient(s): | .5 mg/1 & nbsp; Epoprostenol Sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Epoprostenol Sodium
| Product NDC: | 0703-1985 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078396 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080423 |
Package Information of Epoprostenol Sodium
| Package NDC: | 0703-1985-01 |
| Package Description: | 1 VIAL in 1 CARTON (0703-1985-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Information of Epoprostenol Sodium
| NDC Code | 0703-1985-01 |
| Proprietary Name | Epoprostenol Sodium |
| Package Description | 1 VIAL in 1 CARTON (0703-1985-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 0703-1985 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Epoprostenol Sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080423 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | EPOPROSTENOL SODIUM |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |
